CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,046 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00315393
NCT00315393N/ACompleted
CompareCT.gov

Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

University of Pennsylvania·observational·Posted Apr 18, 2006·Updated Jul 12, 2022

In Brief

An observational study for Granulomatosis With Polyangiitis and 2 related conditions. Completed, enrolled 1,046 participants across 8 sites in 2 countries.

Detailed Summary

Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA) are two rare immune system disorders that cause the inflammation of blood vessels, or vasculitis. In order to properly treat these diseases, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GPA or MPA.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGranulomatosis With Polyangiitis, Microscopic Polyangiitis, Wegener's
CountriesCanada, United States
CollaboratorsOffice of Rare Diseases (ORD), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Rare Diseases Clinical Research Network

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 18, 2006
Enrollment StartApr 1, 2006
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 13.7 yearsPosted 20.2 years ago